(22 days)
Not Found
Not Found
No
The device description details a lateral flow immunoassay that relies on chemical reactions and visual interpretation of colored lines, with no mention of computational analysis, algorithms, or learning processes.
No.
The device is intended to determine pregnancy, not to treat any condition. Therapeutic devices are used for treatment, relief, or prevention of a disease or condition.
Yes
The device is described as aiding in the "determination of pregnancy" by detecting hCG in urine. This process of identifying the presence of a specific condition (pregnancy) through the analysis of a biological sample (urine) aligns with the definition of a diagnostic device.
No
The device description clearly describes a physical test strip that utilizes chemical reactions and capillary action to detect hCG in urine, resulting in the formation of colored lines. This is a hardware-based diagnostic test, not a software-only device.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's for detecting hCG in urine to aid in the determination of pregnancy. This is a diagnostic purpose performed in vitro (outside the body) using a biological sample (urine).
- Device Description: The description details a test that utilizes reagents and a membrane to react with a biological sample (urine) and produce a result (colored lines) based on the presence of a specific analyte (hCG). This is the core mechanism of an in vitro diagnostic test.
- Sample Type: The test uses urine, which is a biological specimen.
- Analyte: The test detects hCG, which is a biological marker.
The fact that it's intended for "non-professional/Over-The Counter" use doesn't change its classification as an IVD. IVDs can be intended for professional use or for home use.
N/A
Intended Use / Indications for Use
The Quik-Check™ Home Pregnancy Test Device is intended for non-professional/Over-the-Counter determination of hCG (human Chorionic Gonadotropin) in urine to aid in the determination of pregnancy.
Product codes
LCX
Device Description
The test utilizes a combination of antibody reagents to selectively detect elevated levels of hCG. The assay is conducted by applying urine to the test device and observing for the migration of the specimen by capillary action along the membrane. This migration facilitates a specific antibody-hCG colored conjugate reaction and the formation of colored lines. Positive specimens react with the colored reagent and form a colored line on the "Test Region" of the membrane. Absence of this suggests a negative result. A colored line on the "Control Region" of the membrane will always appear regardless of the presence or absence of hCG. The Quik-Check™ Home Pregnancy test detects hCG concentrations of 25 mU/ml and greater. The test has been standardized to the World Health Organization Third International Standard. The addition of hCG (human Chorionic Gonadotropin) to negative (0 mlU/ml hCG) and positive (25 mlU/ml hCG) urine showed no cross-reactivity.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
non-professional/Over-The Counter
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical trials using Quik-Check™ Home Pregnancy Test were conducted which included 117 female participants. The results of the study showed the majority of the participants found Quik-Check™ Home Pregnancy Test easy to use and they had no problem understanding the labeling, reading the instructions, or interpreting the results. The overall results of the clinical trial confirm that Quik-Check™ Home Pregnancy Test is a suitable test for over-the-counter pregnancy testing.
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1155 Human chorionic gonadotropin (HCG) test system.
(a)
Human chorionic gonadotropin (HCG) test system intended for the early detection of pregnancy —(1)Identification. A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine.(2)
Classification. Class II.(b)
Human chorionic gonadotropin (HCG) test system intended for any uses other than early detection of pregnancy —(1)Identification. A human chorionic goadotropin (HCG) test system is a device intended for any uses other than early detection of pregnancy (such as an aid in the diagnosis, prognosis, and management of treatment of persons with certain tumors or carcinomas) is intended to measure HCG, a placental hormone, in plasma or urine.(2)
Classification. Class III.(3)
Date PMA or notice of completion of a PDP is required. As of the enactment date of the amendments, May 28, 1976, an approval under section 515 of the act is required before the device described in paragraph (b)(1) may be commercially distributed. See § 862.3.
0
AUG - 7 2001
Summary of Safety & Effectiveness
The Quik-Check™ Home Pregnancy Test Device is intended for non-professional/Over-determination of for the Quik-Checker" Home Pregiancy Tost Dones in thCG) in urine to add in the determination of for the identification of numan Chonomic Golladoneyal (no operioral antibody reagents to selectively pregnancy. The test utilizes a collibination of including unine to the test device and observing for the programments regent with the defect elevated levels of ICC. The assay is conceeded of paillary action along the membrate on formation of comments and forma formation of colored lines. The speciment migrates the specific antibody-hCG-colored conjugate and form a colored conjugate. Postive specificals react with the suggests a negative result.
colored line on the "Test Region" of the membrane. Absence of this suggests anegatives of t colored line on the "rest Region" of the membrant." Hosener of the version will always appear regardless of the presence or absence of hCG.
The Quik-Check™ Home Pregnancy test detects hCG concentrations of 25 mU/ml and geater. The test H has been standardized to the World Health Organization Third International Standard. The addition of M.H.H. has been standardized to the World Italin Organization Introdult to negative (0 mIU/ml hCG) and positive (25 mIU/ml hCG) urine showed no cross-reactivity.
Clinical trials using Quik-Check™ Home Pregnancy Test were conducted which included 117 female Chilical thats using Quile-Chevel - Tremaiority of the participants found Quilt-Check™ Home participants. The results of the study showed and they conferstanding the labeling, reading the instructions, or interpreting the results.
The overall results of the clinical trial confirm that Quik-Check™ Home Pregnancy Test is a suitable test for over-the-counter pregnancy testing.
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three curved lines representing its wings. The eagle is positioned to the right of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA", which is arranged in a circular fashion around the left side of the logo.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
SEP 1 8 2001
Edward Tung, Ph.D. Regulatory Affairs ACON Laboratories, Inc. 4108 Sorrento Valley Blvd. San Diego, CA 92121
510(k) Number: K012215 Re: Trade/Device Name: Quik-Check™Home Pregnancy Test Regulation Number: 862.1155 Regulatory Class: II Product Code: I .C.X Dated: July 10, 2001 Received: July 16, 2001
Dear Dr. Tung:
This letter replaces and corrects letter dated August 7, 2001. The device name was incorrect. It was spelled Quick-Check. It should be spelled Quik-Check.
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such perious on. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal addition, I Drivinal publisher published to your premarket notification submission does not affect reefice. Frease now, ht have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
2
Page 2 -
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed nredicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and 1 additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications For Use
510(k) Number:_ ¥012215_______________________________________________________________________________________________________________________________________________________
Device Name: Quik-Check™ Home Pregnancy Test
"Indications For Use" - Quik-Check™ Home Pregnancy is intended for mon-professional/Over-The Counter Quik-Check - Tome Proghancy is more of hCG (human Chorionic Gonadotropin) in urine to aid in the determination of pregnancy.
(Please do not write below this line)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Kesia Alexander for Jaan varas | |
|---|---|
| (Division Sign-Off) | |
| Division of Clinical Laboratory Devices | |
| 510(k) Number | K012215 |
| Prescription Use | |
|---|---|
| or (per 21 CFR 801.109) | |
| Over-The-Counter Use |